Approval · Notice of Compliance 5039 · 1995
HALCIDERM/PHASE2: Notice of Compliance 5039
Issued December 28, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5039
- Date
- December 28, 1995
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Topical steroid, emollient cream
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALCIDERM/PHASE2 | 02200945 | — |
Medicinal ingredients
- HALCINONIDE 0.1 PER